WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: NGENLA

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on NGENLA

Proof of use for NGENLA

We do not have any records of a proof of use for NGENLA at this moment.

Click here to add a proof of use for NGENLA

Possible trademark infringements of NGENLA

Basic Information about NGENLA

Serial Number
86730692
Filing Date
20 Aug 2015
Registration Number
5692027
Registration Date
05 Mar 2019
Mark Drawing Code
4

Classifications

Declare the trademark use of NGENLA on the blockchain with WikiTrademarks.io.

First use of NGENLA anywhere
NGENLA was first used on 14 Jan 2019 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
005
US Codes
006; 018; 044; 046; 051; 052

Who owns NGENLA?

1. Pfizer Inc. New York NY

2. Pfizer Inc. New York NY

3. Pfizer Inc. New York NY

Correspondent

Janina Gorbach Pfizer Inc.
66 Hudson Boulevard East
New York, NY 10001-2192
United States

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on NGENLA